CollPlant Biotechnologies (CLGN) Preferred Shares Issued (2020 - 2026)
CollPlant Biotechnologies (CLGN) reported Preferred Shares Issued of $1.7 million for Q1 2026, down 94.75% quarter-over-quarter from $32.7 million in Q1 2021.
CollPlant Biotechnologies (CLGN) Preferred Shares Issued (2020 - 2026) Analysis & Trends
CollPlant Biotechnologies has reported Preferred Shares Issued for 3 years, with the latest figure at $1.7 million in Q1 2026.
- For the quarter ending Q1 2026, Preferred Shares Issued changed N/A year-over-year to $1.7 million; the trailing twelve-month figure through Mar 2026 stood at $1.7 million (changed N/A YoY), and the FY2025 full-year result was $3.1 million, changed N/A from the prior year.
- Preferred Shares Issued for Q1 2026 stood at $1.7 million, down from $32.7 million in the prior quarter.
- The five-year high for Preferred Shares Issued was $1.7 million in Q1 2026, with the low at $1.7 million in Q1 2026.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Pref. Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | 1.72 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.72 Mn |
| Mar 31, 2026 | 1.72 Mn |
| Mar 31, 2021 | 32.74 Mn |
| Mar 31, 2021 | 32.74 Mn |
| Jun 30, 2020 | -50,000.00 |
| Jun 30, 2020 | -50,000.00 |
| Mar 31, 2020 | 4.45 Mn |
| Mar 31, 2020 | 4.45 Mn |